What is the Scienture Holdings Inc. stock price forecast?

Scienture Holdings Inc. is currently trading at $0.38. View real-time AI analysis on Alpha Lenz.

What is Scienture Holdings Inc. insider trading activity?

View the latest insider trading data for Scienture Holdings Inc. on Alpha Lenz.

What is Scienture Holdings Inc.'s P/E ratio?

Scienture Holdings Inc.'s P/E ratio is -0.1.

Scienture Holdings Inc.

NASDAQ · SCNX

$0.38+0.00(+0.51%)Pre-market

Ask about Scienture Holdings Inc.'s future dividend policy...

Alpha Chat Insight

“Scienture Holdings Inc. trades at a P/E of -0.1 (undervalued) with modest ROE of -55.6%.”

Ask for details →

Company Overview

Scienture Holdings Inc. is a diversified financial asset that represents a crucial player in the healthcare and biotech sectors. Its primary function revolves around advancing medical and scientific innovations, focusing on biotechnology, pharmaceuticals, and healthcare solutions. As an organization, Scienture Holdings is instrumental in driving research and development initiatives that lead to groundbreaking treatments and technologies. The entity impacts several key industries, including medical research, drug development, diagnostics, and therapeutic technologies. Its operations are essential to advancing global health outcomes and supporting the industry's growth through strategic partnerships and investments. Renowned for fostering innovation, Scienture Holdings contributes significantly to the market by enhancing the quality and accessibility of healthcare solutions, thereby playing a pivotal role in the industry's dynamic landscape.

CEODr. Shankar Hariharan Ph.D.

Websitehttps://scienture.com

SectorHealthcare

IndustryPharmaceutical Retailers

Employees14

Company Statistics

FY 2025

Profile

$5.80MMarket Cap

$431.61KRevenue

0.00Shares Out

14Employees

Margins

76.80%Gross

-3592.08%EBITDA

-3763.78%Operating

-10080.22%Pre-Tax

-9618.03%Net

Valuation

-0.14P/E

0.08P/B

13.44EV/Sales

0.05EV/EBITDA

-0.43P/FCF

Growth (CAGR)

-65.21%Rev 3Yr

-52.10%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-43.92%ROA

-55.65%ROE

-41.71%ROIC

Financial Health

$6.66MCash & Cash Equivalents

$7.40MNet Debt

20.05%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Scienture Holdings Inc. trades at a P/E of -0.1 (undervalued) with modest ROE of -55.6%.”

Ask for details →

Frequently Asked Questions

Scienture Holdings Inc. (ticker: SCNX) is a company listed on NASDAQ in the Healthcare sector (Pharmaceutical Retailers). It has approximately 14 employees. Market cap is $6M.

The current price is $0.378 with a P/E ratio of -0.14x and P/B of 0.08x.

ROE is -55.65% and operating margin is -3763.78%. Annual revenue is $431,609.